Advent International to acquire controlling stake in Avra Laboratories EP News Bureau Jan 25, 2022 The transaction is Advent’s fifth investment in India over the past 12 months
Avra Laboratories gets CDSCO nod for favipiravir API EP News Bureau Jul 28, 2020 The company informed that it is now supplying commercial quantities to Cipla for the launch of Ciplenza
